marin
spong
consid
gold
mine
past
year
respect
divers
secondari
metabolit
biolog
effect
new
metabolit
spong
report
hundr
scientif
paper
review
spong
potenti
provid
futur
drug
import
diseas
cancer
rang
viral
diseas
malaria
inflamm
although
molecular
mode
action
metabolit
still
unclear
substanti
number
compound
mechan
interfer
pathogenesi
wide
rang
diseas
report
knowledg
one
key
factor
necessari
transform
bioactiv
compound
medicin
spong
produc
plethora
chemic
compound
wide
vari
carbon
skeleton
found
interfer
pathogenesi
mani
differ
point
fact
particular
diseas
fought
differ
point
increas
chanc
develop
select
drug
specif
target
relationship
spong
medicin
goe
back
alexandrian
physician
thoroughli
describ
roman
historian
pliniu
physician
use
spong
satur
iodin
stimul
coagul
blood
bioactiv
plant
extract
anesthet
patient
spong
soak
pure
wine
put
left
part
chest
case
heartach
soak
urin
treat
bite
poison
anim
pliniu
recommend
use
spong
sunstrok
use
kind
wound
bone
fractur
dropsi
stomach
ach
infecti
diseas
testicular
tumor
hofricht
sidri
even
implant
breast
oper
arndt
least
sinc
centuri
russian
ukrainian
polish
physician
use
freshwat
spong
call
badiaga
figur
treatment
patient
nozeman
dri
powder
spong
rub
chest
back
patient
lung
diseas
sore
place
case
foot
leg
ach
rheumat
schroder
oficjalski
discov
badiaga
realli
one
spong
mixtur
sever
freshwat
spong
differ
depend
region
poland
consist
powder
euspongilla
lacustri
ephydatia
fluviatili
meyenia
muelleri
russian
badiaga
mixtur
euspongilla
lacustri
ephydatia
fluviatili
spongilla
fragili
carteriu
stepanowi
suggest
high
iodin
concentr
spong
speci
give
rise
wholesom
effect
badiaga
present
stodal
syrup
contain
roast
spongia
officinali
use
homeopath
treatment
dri
asthmat
cough
western
world
stodal
pharmaceut
interest
spong
arous
earli
discoveri
nucleosid
spongothymidin
spongouridin
marin
spong
cryptotethia
crypta
feeney
nucleosid
basi
synthesi
arac
first
marinederiv
anticanc
agent
antivir
drug
araa
proksch
et
al
arac
current
use
routin
treatment
patient
leukemia
lymphoma
one
fluorin
deriv
also
approv
use
patient
pancorrespond
detmer
sipkema
email
detmersipkema
wurnl
creatic
breast
bladder
lung
cancer
schwartsmann
time
reveal
certain
lipid
compon
fatti
acid
sterol
unsaponifi
compound
occur
lower
invertebr
divers
far
greater
encount
among
anim
higher
organ
bergmann
swift
earli
promis
substanti
overwhelm
number
bioactiv
compound
discov
marin
organ
marin
product
describ
thu
marinlit
faulkner
faulkner
faulkner
spong
particular
respons
differ
product
everi
year
hundr
new
compound
discov
faulkner
faulkner
faulkner
bioactiv
compound
spong
classifi
antiinflammatori
antitumor
immunosuppress
neurosuppress
antivir
antimalari
antibiot
antifoul
chemic
divers
spong
product
remark
addit
unusu
nucleosid
bioactiv
terpen
sterol
cyclic
peptid
alkaloid
fatti
acid
peroxid
amino
acid
deriv
frequent
halogen
describ
spong
figur
review
survey
discoveri
product
deriv
marin
spong
attempt
show
varieti
potenti
medic
applic
metabolit
spong
mechan
interfer
pathogenesi
human
diseas
knowledg
prerequisit
develop
drug
bioactiv
compound
exampl
mani
secondari
metabolit
inhibit
growth
cancer
cell
line
impli
suitabl
medicin
cancer
may
exhibit
import
side
effect
follow
section
summar
compound
diseas
type
describ
mode
action
discuss
reason
spong
would
produc
metabolit
antiinflammatori
compound
acut
inflamm
human
bodi
result
microbi
infect
physic
damag
chemic
agent
bodi
react
chang
blood
flow
increas
permeabl
blood
vessel
allow
escap
cell
blood
tissu
tan
et
al
chronic
inflamm
skin
joint
may
sever
damag
bodi
lead
psoriasi
rheumat
arthriti
pope
et
spong
prove
interest
sourc
antiinflammatori
compound
tabl
manoalid
one
first
sesterterpenoid
isol
marin
spong
luffariella
variabili
found
antibiot
de
silva
scheuer
analges
mayer
jacob
addit
antiinflammatori
properti
studi
extens
bennet
et
al
antiinflammatori
action
base
irrevers
inhibit
releas
arachidon
acid
membran
phospholipid
prevent
enzym
phospholipas
bind
membran
glaser
et
al
rise
intracellular
arachidon
acid
concentr
would
lead
upregul
synthesi
inflamm
mediat
prostaglandin
leukotrien
figur
phospholipas
inhibit
record
mani
sesterterpen
spong
order
dictyoceratida
also
bisindol
alkaloid
topsentin
jacob
et
al
mechan
affect
inflamm
process
differ
commonli
use
nonsteroid
antiinflammatori
drug
spongederiv
terpenoid
found
inhibit
lipoxygenas
anoth
enzym
involv
inflammatori
respons
carrol
et
al
antiinflammatori
spong
product
select
inhibitor
specif
enzym
rang
diseas
like
psoriasi
rheumat
arthriti
current
use
nonsteroid
antiinflammatori
drug
often
fail
control
diseas
present
import
side
effect
risk
gastrointestin
bleed
renal
complic
de
rosa
caus
unselect
inhibit
cyclooxygenas
also
involv
promot
product
natur
mucu
protect
gastrointestin
tract
bjarnason
et
al
antitumor
compound
number
isol
spong
compound
inhibitor
protein
kinas
c
pkc
pkc
inhibitor
attract
interest
worldwid
evid
high
level
pkc
enzym
involv
pathogenesi
arthriti
psoriasi
owe
regul
phospholipas
activ
tumor
develop
bradshaw
et
al
yoshiji
et
al
pkc
believ
receptor
protein
tumorpromot
phorbol
ester
pkc
inhibitor
prevent
bind
carcinosarcoma
cell
endothelium
b
liu
et
al
glycosyl
receptor
especi
presenc
fucos
residu
play
import
role
bind
carcinosarcoma
cell
leukocyt
receptor
endothelium
springer
laski
fucosyltransferas
inhibitor
octaand
nonaprenylhydroquinon
sulfat
isol
sarcotragu
sp
wakimoto
et
al
may
therefor
promis
candid
control
inflammatori
process
arthriti
combat
tumor
growth
addit
pkc
inhibitor
fucosyl
transferas
inhibitor
numer
anticanc
molecul
differ
mode
action
discov
marin
spong
tabl
compound
divid
class
nonspecif
inhibitor
cell
growth
specif
inhibitor
cancer
cell
inhibitor
cancer
cell
certain
type
cancer
aforement
pkc
inhibitor
mani
nonspecif
cell
growth
inhibitor
discov
spong
valuabl
treat
cancer
certain
condit
also
affect
divis
healthi
cell
therefor
applic
limit
depend
specif
characterist
cytoskeleton
interest
target
cancer
therapi
microtubul
microfila
involv
cellular
organ
cell
divis
number
adociasulf
triterpenoid
hydroquinon
haticlona
sp
first
inhibitor
kinesin
motor
protein
discov
toxin
believ
inhibit
protein
bind
microtubul
bind
site
lock
motor
function
therebi
block
cell
divis
blackburn
et
al
addit
triterpenoid
hydroquinon
number
potent
microtubuleinterf
compound
discov
marin
spong
halichondrin
b
bai
et
al
spongistatin
bai
et
al
discodermolid
ter
haar
et
al
laulimalid
moobeni
et
al
pelorusid
hood
et
al
dictyostatin
isbruck
et
al
metabolit
latrunculin
latrunculia
magnifica
coue
et
al
swinholid
theonella
swinhoei
bubb
et
al
disrupt
polymer
actin
actin
key
element
microfila
block
mani
cellular
process
includ
cell
divis
spongiacidin
b
inaba
et
al
fascaplysin
soni
et
al
exampl
spongederiv
metabolit
inhibit
cell
divis
inhibit
cyclindepend
kinas
lead
arrest
cell
phase
metabolit
mycalamid
burr
clement
aragusterol
fukuoka
et
al
disturb
cell
divis
inhibit
protein
synthesi
neoamphimedin
de
guzman
et
al
elen
acid
juagdan
et
al
inhibit
develop
tumor
block
topoisomeras
ii
nuclear
enzym
make
transient
dna
break
requir
replic
lf
liu
chen
nitric
oxid
synthetas
inhibitor
imidazol
alkaloid
na
amin
isol
calcar
spong
leucetta
cf
chagosensi
dunbar
et
al
involv
growth
inhibit
cancer
cell
may
prevent
event
earli
phase
tumorigenesi
nitric
oxid
could
particip
tumorigenesi
mediat
dna
fig
inflammatori
cascad
insid
cell
phospholipas
pla
catalyz
releas
membranebound
arachidon
acid
aa
free
arachidon
acid
arachidon
acid
convert
leukotrien
prostaglandin
lipoxygenas
lox
respect
spongederiv
antiinflammatori
molecul
mainli
inhibitor
pla
lox
nonsteroid
antiinflammatori
drug
inhibit
also
constitut
damag
support
tumor
progress
induct
angiogenesi
lala
orucev
howev
inhibit
nitric
oxid
synthetas
may
also
affect
physiolog
process
nitric
oxid
involv
intracellular
transcellular
messag
involv
regul
immunogen
respon
lymphocyt
agelasphin
agela
mauritianu
e
kobayashi
et
al
found
stimul
immun
system
activ
dendrit
natur
killer
nkt
cell
nkt
cell
level
lower
blood
patient
cancer
autoimmun
diseas
type
diabet
shimosaka
mice
shown
tumor
could
reject
stimul
immun
system
agelasphin
yamaguchi
et
al
activ
compound
specif
toward
tumor
cell
multidrug
resist
human
carcinoma
cell
caus
overexpress
two
kind
membran
glycoprotein
revers
agosterol
marin
spong
spongia
sp
suggest
alter
cytosol
ph
play
role
drug
resist
vascular
h
atpas
vatpas
enzym
involv
mani
cellular
process
often
upregul
cancer
cell
acid
vesicular
organel
format
respons
radiat
injuri
manipul
ph
decreas
entri
chemotherapeut
cell
martinezzaguilan
et
al
salicylihamid
isol
haliclona
sp
select
inhibitor
vatpas
shown
cytotox
certain
cancer
cell
normal
noncancer
counterpart
erickson
et
al
first
natur
steroid
isol
cinachyrella
spp
rodriguez
et
al
exampl
molecul
deploy
specif
type
cancer
display
high
affin
aromatas
holland
et
al
ratelimit
enzym
catalyz
convers
androgen
estrogen
figur
blockad
step
allow
treatment
hormonesensit
breast
cancer
depend
estrogen
lon
et
al
peculiar
fact
steroid
chemic
synthes
even
discov
natur
addit
mani
compound
display
growth
inhibit
activ
tumor
cell
line
isol
tabl
immunosuppress
compound
addit
potenti
treatment
cancer
nitric
oxid
synthetas
inhibitor
downregul
tcell
suppress
immun
system
diminish
fierc
migrain
attack
griffith
gross
immun
system
suppress
desir
case
hypersensit
certain
antigen
eg
allergi
organ
transplant
patient
receiv
donor
organ
need
lifelong
medic
prevent
reject
immun
system
reason
extrem
import
medicin
specif
suppressor
therefor
continu
demand
new
immunosuppress
number
new
molecul
immunosuppress
activ
interfer
differ
point
immun
respons
discov
marin
spong
tabl
figur
three
polyoxygen
sterol
dysidea
sp
northern
australia
select
immunosuppress
compound
inhibit
bind
interleukin
cytokin
attract
neutrophil
area
tissu
injuri
receptor
leon
et
al
simplexid
caribbean
spong
plakorti
simplex
group
immunosuppress
glycolipid
inhibit
prolifer
activ
cell
noncytotox
mechan
costantino
et
al
pateamin
mycal
sp
inhibit
product
romo
et
al
therebi
activ
rest
cell
b
cell
lesser
extent
contignasterol
petrosia
contignata
burgoyn
andersen
inhibit
allergeninduc
histamin
releas
rat
mast
cell
takei
et
al
guineapig
lung
tissu
vitro
bramley
et
al
activ
eosinophil
airway
guineapig
could
use
treat
asthma
langland
et
al
cardiovascular
agent
addit
regul
white
blood
cell
number
spongederiv
molecul
found
interfer
bloodrel
diseas
thrombosi
atherosclerosi
diabet
tabl
process
blood
coagul
trigger
complex
proteolyt
cascad
lead
format
fibrin
thrombin
serin
proteas
cleav
peptid
fragment
fibrinogen
lead
gener
fibrin
major
compon
blood
clot
shuman
et
al
cyclotheonarnid
callyspongyn
acid
isol
callyspongia
truncata
aglucosidas
inhibitor
nakao
et
al
aglucosidas
inhibitor
interfer
hydrolysi
glycogen
keep
glucos
concentr
blood
lower
level
use
treat
patient
diabet
lebovitz
compound
keramidin
isol
agela
sp
nakamura
et
al
exampl
number
neurosuppress
compound
isol
marin
spong
tabl
serotonerg
receptor
antagonist
block
serotoninmedi
neural
commun
sever
differ
serotonin
receptor
identifi
relat
platelet
aggreg
may
therefor
use
thrombosi
ruomei
et
al
lundberg
edgar
et
al
addit
abovement
central
act
muscl
relax
mediat
neuromuscular
commun
peripher
act
muscl
relax
may
use
local
muscl
relax
appli
relief
stroke
intub
surgeri
frake
tedania
digitata
quinn
et
al
xestospongin
c
isol
xestospongia
sp
gafni
et
al
exampl
muscl
relax
discov
spong
tabl
xestospongin
c
potent
inhibitor
inositol
ip
receptor
endoplasmicreticulum
ca
pump
de
smet
et
al
inhibit
ip
induc
increas
oscillatori
contract
muscl
miyamoto
et
al
agonist
isol
dysidea
sp
suzuki
et
al
uterorelax
properti
therapeut
use
preterm
deliveri
infant
dennedi
et
al
wide
use
antiasthmat
drug
suzuki
et
al
howev
owe
low
select
agonist
may
sever
side
effect
arteri
hypertens
coroni
heart
diseas
tachycardia
borchard
therefor
continu
interest
find
select
agonist
antivir
compound
spong
also
rich
sourc
compound
antivir
properti
tabl
high
number
hivinhibit
compound
discov
reflect
greater
potenti
spong
fight
aid
compar
viral
diseas
rather
interest
mani
research
strong
focu
screen
antihiv
activ
led
discoveri
numer
compound
mechan
inhibit
still
poorli
character
papuamid
c
ford
et
al
haplosam
b
qureshi
faulkner
avarol
muller
et
al
also
patent
antipsoriasi
exampl
hivinhibit
compound
differ
spong
avarol
one
compound
mechan
inhibit
progress
hiv
infect
less
known
vitro
anim
data
indic
avarol
combin
use
properti
increas
humor
immun
respons
igg
igm
product
significantli
increas
interfer
posttranscript
process
viral
infect
muller
et
al
avarol
inhibit
hiv
almost
complet
block
synthesi
natur
uag
suppressor
glutamin
transfer
trna
synthesi
trna
upregul
viral
infect
import
synthesi
viral
proteas
necessari
viral
prolifer
low
concentr
lm
avarol
result
inhibit
viru
releas
infect
cell
respect
figur
potent
inhibitor
hiv
revers
transcriptas
enzym
key
role
earli
stage
hiv
infect
specif
target
antivir
drug
respons
convert
viral
genom
rna
provir
doublestrand
dna
subsequ
integr
host
chromosom
dna
loya
hizi
addit
applic
treat
diabet
aglucosidas
inhibitor
callyspongymc
acid
potenti
broadbas
antivir
agent
disturb
protein
glycosyl
caus
viral
envelop
protein
misfold
lead
arrest
protein
within
endoplasm
reticulum
protein
fold
take
place
demonstr
alter
glycosyl
pattern
hiv
hepat
b
viru
bovin
viral
diarrhea
viru
aglucosidas
inhibitor
attenu
viral
infect
ratner
et
al
mehta
et
al
differ
class
viru
inhibitor
found
mani
differ
spong
oligoadenyl
involv
interferonmedi
respons
wide
rang
virus
mammal
antivir
action
base
activ
latent
endoribonucleas
prevent
viral
replic
degrad
mrna
well
cellular
rna
kelv
et
al
mani
antivir
mechan
inhibit
still
unclear
activ
rang
virus
hamigeran
b
hamigera
tarangaensi
exampl
show
vitro
inhibit
herp
polio
virus
wellington
et
al
weinbersterol
b
petrosia
weinbergi
exhibit
vitro
activ
felin
leukemia
viru
mous
influenza
viru
mous
corona
viru
sun
et
al
koehn
et
al
gener
antivir
molecul
spong
give
protect
virus
may
result
drug
treat
alreadi
infect
person
addit
broadbas
antivir
agent
aglucosidas
inhibitor
may
use
case
sudden
outbreak
unfamiliar
virus
like
sar
ebola
antimalari
compound
sever
spongederiv
antimalari
compound
discov
last
decad
tabl
new
antimalari
drug
need
cope
increas
number
multidrugresist
plasmodium
strain
caus
malaria
plasmodium
falciparum
becom
resist
chloroquinon
pyrimethamin
sulfadoxin
bwijo
et
al
kalihinol
acanthella
sp
miyaoka
et
al
number
terpenoid
isocyan
isothiocyan
isonitril
cymbastela
hooperi
konig
et
al
display
select
vitro
antimalari
activ
p
falciparum
also
number
free
carboxyl
acid
diacarnu
levii
use
precursor
yield
new
cyclic
norditerpen
peroxid
esterif
epidioxysubstitut
norditerpen
norsesterterpen
display
select
activ
chloroquinesensit
chloroquineresist
p
falciparum
strain
ambrosio
et
al
manzamin
promis
antimalari
compound
discov
number
spong
sakai
et
al
ang
et
al
youssaf
et
al
suggest
antimalari
effect
manzamin
due
enhanc
immun
respons
ang
et
al
antibiot
fungicid
respect
antibiot
fungicid
similar
multiresist
problem
concern
physician
long
time
mani
new
molecul
antibiot
properti
discov
everi
year
marin
spong
ubiqu
remark
tabl
earli
screen
burkhold
ruetzler
reveal
spong
test
show
antimicrobi
effect
strong
rang
gramposit
gramneg
bacteria
ad
valu
new
spongederiv
antibiot
shown
inhibitori
effect
arenosclerin
ac
arenosclera
brasiliensi
antibioticresist
bacteria
isol
hospit
torr
et
al
fungicid
current
use
less
divers
antimicrobi
use
mani
restrict
toxic
effect
human
anim
plant
nakagawa
moor
rahdenstaron
remain
demonstr
whether
antifung
like
topsentiasterol
e
topsentia
sp
fusetani
et
al
acanthosterol
sulfat
j
acanthodendrilla
sp
tsukamoto
et
al
macrolid
leucascandrolid
calcar
spong
leucascandra
caveolata
et
al
differ
characterist
fungicid
current
use
fact
produc
eukaryot
organ
produc
symbiont
may
impli
less
toxic
nonfung
eukaryot
antifoul
compound
last
class
bioactiv
compound
marin
spong
antifoul
molecul
tabl
associ
develop
new
drug
could
environment
friendli
substitut
chemic
antifoul
biofoul
organ
blue
mussel
barnacl
macroalga
caus
seriou
problem
hull
cool
system
power
plant
aquacultur
materi
holm
houghton
longterm
use
chemic
antifoul
led
increas
concentr
tributyltin
current
replac
coastal
sediment
konstantin
albani
mortal
chang
sex
nontarget
organ
katranitsa
et
al
natur
marin
antifoul
molecul
recent
review
fusetani
may
provid
less
toxic
specif
antifoul
activ
spongederiv
antifoul
molecul
found
inhibit
settlement
barnacl
larva
okino
et
al
sera
et
al
ecolog
role
spong
metabolit
extens
collect
spongederiv
bioactiv
compound
rais
question
spong
produc
mani
metabolit
use
treat
human
diseas
huge
number
differ
secondari
metabolit
discov
marin
spong
complex
compound
biosynthet
pathway
correspond
kilobas
dna
program
synthesi
regard
indic
import
surviv
obviou
exampl
benefit
secondari
metabolit
spong
presenc
antifoul
product
safeguard
waterpump
capac
spong
toler
biofilm
format
settlement
barnacl
bryozoan
surfac
proksch
level
cytotox
spong
product
high
enough
even
creat
bare
zone
around
spong
thompson
maintain
emiss
mucu
contain
toxin
sullivan
et
al
allow
conquest
dens
popul
rock
coral
competit
faster
grow
organ
strike
spong
select
use
poison
without
selfdestruct
secondari
metabolit
protect
organ
predat
especi
import
physic
unprotect
sessil
organ
like
spong
becerro
et
al
rel
anim
hawksbil
turtl
highli
evolv
teleost
fish
meylan
larg
depend
spong
diet
also
nudibranch
feed
spong
even
manag
use
metabolit
chemic
defenc
pawlik
et
al
howev
spongivor
repres
tini
fraction
anim
inhabit
sea
secondari
metabolit
also
protect
produc
bacteria
fungi
parasit
davi
spong
role
chemic
constitu
cloud
complex
spongesymbiont
relationship
dumdei
et
al
mani
differ
bacteri
speci
perman
inhabit
spong
contribut
consider
total
spong
biomass
wilkinson
suggest
growth
use
microorgan
may
control
spong
host
serv
sourc
food
suppli
metabol
product
muller
et
al
howev
also
found
associ
bacteria
might
actual
produc
number
compound
tabl
isol
spong
oscillatoria
spongelia
cyanobacteri
symbiont
constitut
dysidea
herbacea
produc
antimicrobi
polybromin
biphenyl
ether
might
keep
spong
free
bacteria
unson
et
al
mani
product
yet
known
whether
produc
spong
symbiont
clear
howev
spong
respons
product
rich
arsen
chemic
weapon
earli
appear
evolut
given
lot
time
develop
advanc
chemic
defens
system
interest
note
synthesi
secondari
metabolit
regul
depend
condit
spong
experi
specimen
cramb
cramb
wellillumin
region
grow
faster
counterpart
expos
darker
condit
specimen
dark
better
defend
accumul
higher
concentr
cytotox
metabolit
turon
et
al
anoth
exampl
product
halichondrin
b
lissodendoryx
sp
vari
season
depth
condit
spong
halichondrin
b
yield
could
enhanc
order
magnitud
serial
clone
suggest
defens
respons
damag
battershil
et
al
abil
stimul
product
secondari
metabolit
spong
import
consider
one
want
harvest
compound
spong
product
potenti
new
medicin
marin
spong
produc
enorm
array
antitumor
antivir
antiinflammatori
immunosuppress
antibiot
bioactiv
molecul
affect
pathogenesi
mani
human
diseas
relationship
chemic
structur
secondari
metabolit
spong
diseas
affect
usual
obviou
differ
compon
affect
target
diseas
differ
mechan
eg
microtubul
stabil
interact
dna
combat
tumor
moreov
inhibitor
transcript
may
effect
cancer
viral
diseas
make
thing
complex
mani
relat
instanc
inflamm
cancer
viral
infect
via
immun
system
play
key
role
certain
respons
bodi
diseas
chronic
inflamm
lung
cigarett
smoke
often
lead
lung
cancer
ohwada
et
al
cervic
liver
cancer
follow
chronic
inflamm
caus
papilloma
virus
smithmccun
et
al
hepat
b
c
virus
respect
zhu
et
al
addit
limit
activ
test
eg
cell
growth
inhibit
antivir
properti
yield
incomplet
overview
actual
properti
metabolit
final
mani
bioactiv
molecul
spong
exact
mode
action
origin
spong
symbiont
still
unclear
bioactiv
metabolit
spong
inhibitor
certain
enzym
often
mediat
produc
mediat
intracellular
intercellular
messeng
involv
pathogenesi
diseas
usual
cascad
reaction
insid
cell
tissu
mani
enzym
cascad
target
potenti
therapi
differ
enzym
cascad
structur
complet
differ
protein
therefor
surpris
wide
rang
metabolit
use
treatment
one
diseas
appli
particular
complex
diseas
cancer
affect
mani
differ
factor
furthermor
antivir
molecul
also
appear
encamp
wide
array
chemic
structur
peptid
lipid
alkaloid
sterol
oligonucleotid
phenol
macrolid
similar
divers
pattern
observ
antibacteri
immunosuppress
metabolit
compound
display
antiinflammatori
activ
sesterterpenoid
nevertheless
case
activ
spong
metabolit
concentr
certain
step
instanc
antiinflammatori
compound
act
phospholipas
potenc
spongederiv
medicin
lie
fact
thousand
metabolit
deriv
specif
doserel
inhibitori
effect
efficaci
potenti
diminish
side
effect
determin
suitabl
medicin
use
addit
skeleton
activ
core
molecul
may
use
vehicl
develop
deriv
specif
efficaci
side
effect
therefor
import
challeng
transform
bioactiv
molecul
medicin
screen
treasurehous
spong
metabolit
select
display
specif
mode
action
desir
characterist
diseas
import
question
futur
remain
actual
prepar
potenti
novel
drug
larg
scale
